Peptide Vials (NAD+, 1000 mg each): 8 weeks 6 vials (total 5,075 mg used) 12 weeks 8 vials (total 7,875 mg used) 16 weeks 11 vials (total 10,675 mg used) Insulin Syringes (U100, 1 mL): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Luteolin protects against fatty liver by improving intestinal barrier integrity
Kidney Impact: Similar to other NSAIDs, it can impair renal function, particularly in dehydrated patients or those with existing kidney problems
BPC-157 is not approved for human use and is not presented as a medical treatment
In theory, that means more staggering weight-loss results and potentially other benefits
The clinical data suggesting a possible association come from post-marketing surveillance data that have substantial risk for bias and do not control for important confounding variables